Cosmo Pharmaceuticals N.V. (SWX:COPN)

Cosmo Pharmaceuticals Revenue

Cosmo Pharmaceuticals had revenue of 51.72M EUR in the half year ending June 30, 2025, with 18.46% growth. This brings the company's revenue in the last twelve months to 182.27M, down -1.66% year-over-year. In the year 2024, Cosmo Pharmaceuticals had annual revenue of 266.79M with 187.55% growth.

• Revenue (ttm): 182.27M EUR
• Revenue Growth: -1.66%
• P/S Ratio: 5.20
• Revenue / Employee: 566.41K EUR
• Employees: 322
• Market Cap: 884.61M CHF

Revenue Chart

* This company reports financials in EUR.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	266.79M	174.01M	187.55%
Dec 31, 2023	92.78M	-9.31M	-9.12%
Dec 31, 2022	102.09M	37.02M	56.88%
Dec 31, 2021	65.07M	4.13M	6.77%
Dec 31, 2020	60.95M	-1.55M	-2.47%